Publicacións en colaboración con investigadores/as de University of Paris-Sorbonne (4)

2024

  1. Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study

    The Lancet Haematology, Vol. 11, Núm. 3, pp. e206-e215

2022

  1. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

    Bone Marrow Transplantation, Vol. 57, Núm. 3, pp. 416-422

  2. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (Bone Marrow Transplantation, (2022), 57, 3, (416-422), 10.1038/s41409-021-01553-x)

    Bone Marrow Transplantation

  3. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

    New England Journal of Medicine, Vol. 386, Núm. 1, pp. 11-23